Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
21.31
+1.50 (7.57%)
At close: Jun 26, 2026, 4:00 PM EDT
21.25
-0.06 (-0.28%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Syndax Pharmaceuticals Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Syndax Pharmaceuticals stock have an average target of 41, with a low estimate of 29 and a high estimate of 57. The average target predicts an increase of 92.40% from the current stock price of 21.31.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Syndax Pharmaceuticals stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 11 | 11 | 11 | 11 | 11 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 13 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $46 | Buy | Maintains | $46 | +115.86% | Jun 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $40 | Buy | Reiterates | $40 | +87.71% | Jun 15, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $34 → $31 | Buy | Maintains | $34 → $31 | +45.47% | Jun 12, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $34 | Buy | Maintains | $34 | +59.55% | Jun 4, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $29 | Buy | Maintains | $29 | +36.09% | May 21, 2026 |
Financial Forecast
Revenue This Year
344.51M
from 172.35M
Increased by 99.89%
Revenue Next Year
502.75M
from 344.51M
Increased by 45.93%
EPS This Year
-1.70
from -3.29
EPS Next Year
-0.56
from -1.70
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 379.3M | 643.8M | |
| Avg | 344.5M | 502.8M | |
| Low | 298.5M | 405.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 120.1% | 86.9% | |
| Avg | 99.9% | 45.9% | |
| Low | 73.2% | 17.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.16 | 0.43 | |
| Avg | -1.70 | -0.56 | |
| Low | -2.71 | -2.22 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.